202 related articles for article (PubMed ID: 25627342)
1. Long-term effect of antiviral therapy on disease course after decompensation in patients with hepatitis B virus-related cirrhosis.
Jang JW; Choi JY; Kim YS; Woo HY; Choi SK; Lee CH; Kim TY; Sohn JH; Tak WY; Han KH
Hepatology; 2015 Jun; 61(6):1809-20. PubMed ID: 25627342
[TBL] [Abstract][Full Text] [Related]
2. Determinants of early mortality and benefits of lamivudine therapy in patients with hepatitis B virus-related decompensated liver cirrhosis.
Tseng PL; Lu SN; Tung HD; Wang JH; Changchien CS; Lee CM
J Viral Hepat; 2005 Jul; 12(4):386-92. PubMed ID: 15985009
[TBL] [Abstract][Full Text] [Related]
3. Effects of Virologic Response to Treatment on Short- and Long-term Outcomes of Patients With Chronic Hepatitis B Virus Infection and Decompensated Cirrhosis.
Jang JW; Choi JY; Kim YS; Yoo JJ; Woo HY; Choi SK; Jun CH; Lee CH; Sohn JH; Tak WY; Lee YR; Han KH
Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1954-1963.e3. PubMed ID: 29753085
[TBL] [Abstract][Full Text] [Related]
4. Long-term lamivudine monotherapy in renal-transplant recipients with hepatitis-B-related cirrhosis.
Viganò M; Colombo M; Aroldi A; Lunghi G; Manenti E; Ponticelli C; Lampertico P
Antivir Ther; 2005; 10(6):709-13. PubMed ID: 16218169
[TBL] [Abstract][Full Text] [Related]
5. Prognosis of hepatitis B-related liver cirrhosis in the era of oral nucleos(t)ide analog antiviral agents.
Kim CH; Um SH; Seo YS; Jung JY; Kim JD; Yim HJ; Keum B; Kim YS; Jeen YT; Lee HS; Chun HJ; Kim CD; Ryu HS
J Gastroenterol Hepatol; 2012 Oct; 27(10):1589-95. PubMed ID: 22554121
[TBL] [Abstract][Full Text] [Related]
6. Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis.
Zoutendijk R; Reijnders JG; Zoulim F; Brown A; Mutimer DJ; Deterding K; Hofmann WP; Petersen J; Fasano M; Buti M; Berg T; Hansen BE; Sonneveld MJ; Wedemeyer H; Janssen HL;
Gut; 2013 May; 62(5):760-5. PubMed ID: 22490523
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus-related decompensated cirrhosis.
Hyun JJ; Seo YS; Yoon E; Kim TH; Kim DJ; Kang HS; Jung ES; Kim JH; An H; Kim JH; Yim HJ; Yeon JE; Lee HS; Byun KS; Um SH; Kim CD; Ryu HS
Liver Int; 2012 Apr; 32(4):656-64. PubMed ID: 22099071
[TBL] [Abstract][Full Text] [Related]
8. Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B.
Fontana RJ; Keeffe EB; Carey W; Fried M; Reddy R; Kowdley KV; Soldevila-Pico C; McClure LA; Lok AS;
Liver Transpl; 2002 May; 8(5):433-9. PubMed ID: 12004342
[TBL] [Abstract][Full Text] [Related]
9. Effect of lamivudine treatment in patients with decompensated cirrhosis due to anti-HBe positive/HBeAg-negative chronic hepatitis B.
Nikolaidis N; Vassiliadis T; Giouleme O; Tziomalos K; Grammatikos N; Patsiaoura K; Orfanou-Koumerkeridou E; Balaska A; Eugenidis N
Clin Transplant; 2005 Jun; 19(3):321-6. PubMed ID: 15877792
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of lamivudine-adefovir therapy in chronic hepatitis B cirrhosis.
Lim SG; Aung MO; Mak B; Sutedja D; Lee YM; Lee GH; Fernandes M; Low HC; Lai V; Dan YY
J Clin Gastroenterol; 2011 Oct; 45(9):818-23. PubMed ID: 21921845
[TBL] [Abstract][Full Text] [Related]
11. Effect of virological response to entecavir on the development of hepatocellular carcinoma in hepatitis B viral cirrhotic patients: comparison between compensated and decompensated cirrhosis.
Kim SS; Hwang JC; Lim SG; Ahn SJ; Cheong JY; Cho SW
Am J Gastroenterol; 2014 Aug; 109(8):1223-33. PubMed ID: 24890440
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of tenofovir in chronic hepatitis B-related decompensated cirrhosis.
Lee SK; Song MJ; Kim SH; Lee BS; Lee TH; Kang YW; Kim SB; Song IH; Chae HB; Ko SY; Lee JD
World J Gastroenterol; 2017 Apr; 23(13):2396-2403. PubMed ID: 28428719
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of entecavir in treatment-naïve patients with hepatitis B virus-related decompensated cirrhosis.
Shim JH; Lee HC; Kim KM; Lim YS; Chung YH; Lee YS; Suh DJ
J Hepatol; 2010 Feb; 52(2):176-82. PubMed ID: 20006394
[TBL] [Abstract][Full Text] [Related]
14. Clinical improvement in patients with decompensated liver disease caused by hepatitis B after treatment with lamivudine.
Sponseller CA; Bacon BR; Di Bisceglie AM
Liver Transpl; 2000 Nov; 6(6):715-20. PubMed ID: 11084057
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy.
Peng CY; Chien RN; Liaw YF
J Hepatol; 2012 Aug; 57(2):442-50. PubMed ID: 22504333
[TBL] [Abstract][Full Text] [Related]
16. [Effects of oral antiviral agents on long-term outcomes of treatment-naive patients with HBV-related decompensated cirrhosis: a retrospective cohort study].
Hu P; Zhao GD; Li H; Gao T; Li ST; Tang WL; Zhou HJ; Wang H; Xie Q
Zhonghua Gan Zang Bing Za Zhi; 2014 Nov; 22(11):806-11. PubMed ID: 25531375
[TBL] [Abstract][Full Text] [Related]
17. Predictors of survival in hepatitis B virus related decompensated cirrhosis on tenofovir therapy: an Indian perspective.
Srivastava M; Rungta S; Dixit VK; Shukla SK; Singh TB; Jain AK
Antiviral Res; 2013 Nov; 100(2):300-5. PubMed ID: 24012998
[TBL] [Abstract][Full Text] [Related]
18. Antiviral therapy for hepatitis B virus-related decompensated cirrhosis.
Wang JY
J Dig Dis; 2012 Nov; 13(11):555-7. PubMed ID: 23107441
[TBL] [Abstract][Full Text] [Related]
19. Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.
Jin YJ; Shim JH; Lee HC; Yoo DJ; Kim KM; Lim YS; Suh DJ
J Gastroenterol Hepatol; 2011 Sep; 26(9):1380-8. PubMed ID: 21884247
[TBL] [Abstract][Full Text] [Related]
20. HBV-DNA suppression and disease course in HBV cirrhosis patients on long-term lamivudine therapy.
Di Marco V; Di Stefano R; Ferraro D; Almasio PL; Bonura C; Giglio M; Parisi P; Cappello M; Alaimo G; Craxì A
Antivir Ther; 2005; 10(3):431-9. PubMed ID: 15918334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
